35 results
8-K
EX-1.1
TCRX
Tscan Therapeutics Inc
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (“Environmental … Laws”), (ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
8-K
EX-1.1
xu1dxkyq c7ewtwu
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am
8-K
EX-1.1
ab26i6a39 j6bqzo
16 May 23
Other Events
5:21pm
8-K
EX-99.1
a0zt4ozden9jdcon 67
9 May 23
Amgen and Tscan Therapeutics Announce Collaboration to Identify Novel Targets In Crohn’s Disease
9:15am
8-K
EX-10.1
rh17ka3
12 Sep 22
TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures
7:51am
DEF 14A
3hzqouucgn6x7fifd23
21 Apr 22
Definitive proxy
8:00am
10-K
i353pj kt
9 Mar 22
Annual report
7:30am
8-K
EX-10.1
4mp2xfqe6cpo4xj
2 Dec 21
Entry into a Material Definitive Agreement
7:31am